![]() |
市場調查報告書
商品編碼
1827724
2025年全球透析設備市場報告Dialyzers Global Market Report 2025 |
近年來,透析設備市場規模穩定成長,從2024年的22.4億美元增加至2025年的23.4億美元,複合年成長率為4.5%。預測期內的成長歸因於人口老化、醫療基礎設施的改善、研發的加強以及透析中心數量的增加。
預計未來幾年透析設備市場規模將強勁成長,2029年將達到30.6億美元,複合年成長率為7.0%。預測期內的成長主要受以下因素驅動:慢性腎臟病率上升、可支配收入增加、醫療支出增加以及家庭透析治療治療需求的增加。預測期內的主要趨勢包括穿戴式透析設備、人工智慧 (AI) 整合、遠端監控、基於價值的護理模式以及生物工程。
透析機是醫療設備,用於在腎臟功能不正常時過濾廢物並去除血液中多餘的水分。它通過半透膜,利用不均勻擴散作用分離溶液中的化合物,從而取代腎臟。這個過程可以有效過濾腎衰竭患者血液中的污染物。
透析設備主要分為高透析設備和低通量透析設備兩種。高通量透析透析設備孔徑較大,能夠去除較大的分子,例如BETA-2微球蛋白。這類透析設備分為一次性透析機和可重複使用透析機,可用於多種場合,包括中心透析、家庭透析治療、血液透析機。
2025年春季美國關稅突然上調及其引發的貿易摩擦,對醫療設備領域產生了重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰進一步加劇了形勢,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場准入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供透析設備市場統計數據,例如全球市場規模、區域佔有率、競爭對手的透析設備透析設備市場佔有率、詳細的透析設備細分市場、市場趨勢和機遇,以及在透析設備行業取得成功所需的數據。本透析設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。
未來五年7.0%的預測成長率,較我們先前對該市場的預測略有下降0.3%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自英國和丹麥等主要地區的中空纖維膜和生物相容性灌封膠徵收關稅直接影響美國,從而可能導致救命過濾裝置短缺,並推高末期腎臟病的治療成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,其影響將更為廣泛。
末期腎功能衰竭(ESRF),也稱為末期末期腎功能衰竭(ESRD) 的盛行率不斷上升,代表著慢性腎臟病的最後不可逆階段,此時透析設備功能下降到無法再獨立運作的程度。透析是為了清除血液中的廢物和多餘的液體,並將過濾的血液送回體內。例如,2024 年 6 月,致力於預防可預防腎臟病的印度組織國家腎臟基金會報告稱,到 2023 年,美國將有大約 3550 萬人被診斷出患有慢性腎臟病,佔成年人的 33%,即超過三分之一。此外,黑人/非裔美國人占美國人口的 13%,但佔慢性腎臟病患者的 30%。腎臟病患者約佔所有醫療保險支出的四分之一,總額達 1567 億美元,而且還在增加。因此,末期腎功能衰竭的上升正在推動透析設備市場的成長。
糖尿病和心血管疾病的盛行率上升是透析設備市場成長的驅動力。糖尿病和心血管疾病會帶來嚴重的健康風險,血糖值升高會增加心臟相關疾病的可能性。糖尿病和心血管疾病患者使用透析設備清除血液中的廢物和多餘液體,解決潛在的腎功能障礙和過濾障礙,從而控制併發症並改善整體健康。根據世界衛生組織 (WHO) 的數據,慢性病佔全球死亡人數的 74%,每年導致 4,100 萬人死亡。這些死亡包括 1,790 萬人死於心血管疾病,930 萬人死於癌症,410 萬人死於慢性呼吸道疾病,200 萬人死於糖尿病。糖尿病和心血管疾病發生率的上升正在推動透析設備市場的擴張。
為了確保可靠的患者照護,透析設備市場的主要企業正專注於開發血液相容性透析設備等創新產品。血液相容性透析設備經過特殊設計,可抑制血液凝固系統的活化和發炎反應,進而降低透析過程中併發症的風險,例如血栓、出血和感染疾病。例如,2024 年 2 月,德國製造商費森尤斯醫療保健股份公司推出了 5,008X血液透析機系統。該系統及其配套的 FX CorAL透析設備展示了該公司在醫療設備和膜工程創新方面的全球領導地位。 5008X血液透析機系統整合了先進的設備工程和薄膜技術,可實現大容量血液透析機。
透析設備市場的主要企業正在尋求策略夥伴關係關係,以改善末期腎功能衰竭(ESRD) 患者的生活品質 (QOL) 和整體患者照護體驗。策略夥伴關係關係是指公司利用彼此的優勢和資源,實現互利共贏。例如,2023 年 9 月,美國醫療科技公司 Alio Inc. 與美國醫療保健公司 Lifeline Vascular Care 合作,為其 SmartPatch 遠端監控平台引入一項新功能。此功能會提醒臨床醫師注意患者血管通路部位的異常聲學資料。此次合作旨在透過實現主動監控而無需頻繁就診,從而改善患者管理,特別是針對末期腎病 (ESKD) 患者。
另一項策略性舉措是,德國知名透析設備製造商 B. Braun SE 於 2022 年 3 月收購了 Intermedt Medizin & Technik GmbH,收購金額未揭露。此次策略性收購將使 B. Braun 能夠獲得 Intermedt 提供的全面透析產品和服務,從而加強和擴展產品系列。 Intermedt Medizin & Technik GmbH 是一家德國專業的透析設備和透析濃縮液製造商,將成為 B. Braun 在透析設備市場戰略成長和發展不可或缺的一部分。透過此類策略舉措,透析設備市場的主要企業不僅在加強其產品供應,而且還在利用合作夥伴關係和收購來塑造末期腎臟病領域患者照護的未來格局。
透析設備市場的一些主要企業包括美敦力公司、旭化成醫療株式會社、東麗醫療株式會社、百特國際公司、貝朗梅爾松根股份公司、泰爾茂株式會社、尼普洛株式會社、日機裝株式會社、威高西克醫療有限公司、Xmedon 醫療產品公司、Emed 醫療公司醫療有限公司、醫學有限公司、費森尤斯醫療公司醫療有限公司、Emed 醫療有限公司醫療有限公司、醫學有限公司、Fxentage 醫療有限公司醫療公司醫療有限公司、醫學 醫療有限公司醫療有限公司醫療有限公司、Fxentage 醫療有限公司醫療有限公司醫療有限公司醫療有限公司醫療有限公司、醫學 醫療有限公司醫療有限公司)股份公司、川澄製藥股份有限公司、Dialife SA、安徽金業實業有限公司、Haidylena 和 Farmasol SA。
2024 年,北美是透析設備市場最大的地區。報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。
透析設備市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。
透析設備市場由提供諸如去除多餘液體和過濾血液中的廢物等服務的營業單位所獲得的收益所構成。市場規模還包括服務提供者銷售或包含在其服務產品中的相關商品的價值。透析設備市場包括管式透析設備、平板式透析設備和中空纖維透析設備的銷售。該市場的價值是“出廠價”,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。
A dialyzer is a medical device utilized for filtering waste chemicals and eliminating excess fluid from an individual's blood in cases where the kidneys are not functioning properly. It acts as a substitute for the kidneys by employing semipermeable membranes to separate compounds in solution through uneven diffusion. This process effectively filters pollutants from the bloodstream of patients with kidney malfunction.
The primary types of dialyzers are high-flux dialyzers and low-flux dialyzers. High-flux dialyzers feature larger holes, allowing them to remove larger molecules such as beta-2 microglobulin. These dialyzers can be categorized based on their usage as disposable or reusable and can be employed in various settings, including in-center dialysis, home dialysis, hospital dialysis, independent dialysis, peritoneal dialysis, and home hemodialysis.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The dialyzers market research report is one of a series of new reports from The Business Research Company that provides dialyzers market statistics, including dialyzers industry global market size, regional shares, competitors with a dialyzers market share, detailed dialyzers market segments, market trends and opportunities, and any further data you may need to thrive in the dialyzers industry. This dialyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dialyzers market size has grown steadily in recent years. It will grow from $2.24 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to aging population, improved healthcare infrastructure, rise in research and development, increase in number of dialysis centers.
The dialyzers market size is expected to see strong growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing prevalence of chronic kidney diseases, rising disposable income, rising healthcare expenditure, growing demand for home dialysis treatment. Major trends in the forecast period include wearable dialysis devices, artificial intelligence (ai) integration, remote monitoring, value-based care models, bioengineered dialyzers.
The forecast of 7.0% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on hollow fiber membranes and biocompatible potting compounds, sourced from key regions such as the UK and Denmark, which could lead to shortages in life-saving filtration devices and higher costs for end-stage renal disease treatment.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of end-stage renal disease is anticipated to drive the growth of the dialyzer market in the near future. End-stage renal failure (ESRF), also known as end-stage renal disease (ESRD), represents the final, irreversible stage of chronic kidney disease, during which kidney function has declined to a level that the kidneys can no longer function independently. A dialyzer is utilized in the dialysis process to remove waste and excess fluid from the bloodstream, subsequently reinfusing the filtered blood back into the body of patients with end-stage renal disease. For example, in June 2024, the National Kidney Foundation, an organization based in India focused on combating preventable kidney disease, reported that nearly 35.5 million people in the US were diagnosed with chronic kidney disease by 2023, accounting for 33 percent of adults, or more than one in three. Additionally, while Black/African American individuals make up 13% of the U.S. population, they represent 30% of all kidney failure cases. Kidney patients receive about one-fourth of all Medicare expenditures, amounting to $156.7 billion and increasing. Thus, the rising incidence of end-stage renal disease is fueling the growth of the dialyzer market.
The rising rates of diabetes and cardiovascular disease are poised to propel the dialyzer market's growth. Diabetes and cardiovascular disease pose significant health risks, with elevated blood sugar levels contributing to an increased likelihood of heart-related conditions. Patients afflicted with diabetes and cardiovascular disease utilize dialyzers to eliminate waste products and excess fluids from their bloodstream, managing complications and enhancing overall health by addressing potential kidney dysfunction and impaired filtration. According to the World Health Organization, chronic diseases account for 74% of global fatalities, with 41 million deaths annually, encompassing 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. The mounting rates of diabetes and cardiovascular disease underscore the driving force behind the dialyzer market's expansion.
Major companies in the dialyzer market are concentrating on developing innovative products, such as hemocompatible dialyzers, to ensure reliable patient care. A hemocompatible dialyzer is specifically designed to reduce the activation of the blood's clotting system and the inflammatory response, thereby lowering the risk of complications during dialysis, including blood clots, bleeding, and infections. For example, in February 2024, Fresenius Medical Care AG & Co. KGaA, a German manufacturer of dialyzers, introduced the 5008X Hemodialysis System. This system and its accompanying FX CorAL dialyzer demonstrate the company's global leadership in innovation within medical device and membrane engineering technologies. The 5008X Hemodialysis System integrates advanced device engineering with membrane technologies to facilitate high-volume hemodiafiltration.
Major companies in the dialyzer market are pursuing a strategic partnership approach to enhance the quality of life and overall patient care experience for individuals with end-stage renal disease (ESRD). Strategic partnerships involve companies utilizing each other's strengths and resources to achieve mutual benefits and success. For example, in September 2023, Alio Inc., a US-based medtech company, collaborated with Lifeline Vascular Care, a US-based medical firm, to introduce a new feature for its SmartPatch remote monitoring platform. This feature alerts clinicians to unusual acoustic data from a patient's vascular access site. The goal of this partnership is to improve patient management, particularly for those with end-stage kidney disease (ESKD), by enabling proactive monitoring without the necessity for frequent in-person visits.
In another strategic move, B. Braun SE, a prominent Germany-based manufacturer of dialyzers, executed an acquisition in March 2022 by acquiring Intermedt Medizin & Technik GmbH for an undisclosed amount. This strategic acquisition positions B. Braun to fortify and expand its product portfolio by gaining access to the comprehensive range of dialysis products and services offered by Intermedt. As a Germany-based manufacturer specializing in dialyzers and dialysis concentrates, Intermedt Medizin & Technik GmbH becomes an integral component of B. Braun's strategic growth and development in the dialyzer market. Through such strategic initiatives, major companies in the dialyzer market are not only enhancing their product offerings but also leveraging collaborations and acquisitions to shape the future landscape of patient care in the realm of end-stage renal disease.
Major companies operating in the dialyzers market include Medtronic PLC, Asahi Kasei Medical Co Ltd., Toray Medical Co Ltd., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Nikkiso Co Ltd., Weigao group, Fresenius Medical Care AG & Co KGaA, Allmed Medical Products Co Ltd., NxStage Medical Inc., Jiangxi Sanxin Medical Technology Co Ltd., Rockwell Medical Inc., Xenios AG., Kawasumi Laboratories Incorporated., Dialife SA, Anhui Jinye Industrial Co Ltd., Haidylena, and Farmasol S.A
North America was the largest region in the dialyzers market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Dialyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The dialyzer market consists of revenues earned by entities by providing services such as removal of excess fluid, filtering blood from waste products. The market value includes the value of related goods sold by the service provider or included within the service offering. The dialyzer market also consists of sales of tube-type dialyzers, flat-type dialyzers, and hollow fiber-type dialyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dialyzers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dialyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for dialyzers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dialyzers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.